openPR Logo
Press release

Analysis of Male Cancer in Global Industry : Demands, Insights, Research and Forecast 2017-2020

05-17-2017 02:30 PM CET | Health & Medicine

Press release from: Male Cancer

ALBANY, NY, May 17, 2017 : Cancer, according to the WHO resulted in the death of around 8.2 million individuals worldwide in 2012. Around 14% of the world’s total annual deaths are as a result of various cancers. Modern medicine has extended the life expectancy of a cancer patient by a great margin. However newer cases are diagnosed every year globally, there is at present 14 million newly diagnosed individuals annually, according to the WHO. This is commonly as a result of the changing lifestyles, unhealthy diet, hereditary factors and exposure to carcinogenic elements. Nearly half of the general cancer cases that include: colorectal cancer, lymphoma, carcinoma, and lung cancer; are presented by men. This also includes breast cancer cases, where around 1% of the cases are exhibited by males worldwide. Male specific cancers include: prostate cancer, testicular cancer, and penile cancer.

Among these, according to the WHO, the most common cause of death in men is prostate cancer. Male specific cancers are generally benign/malignant tumors that rarely undergo metastasis. A majority of disease complications are due to metastasis of cancers that result in complete peripheral organ damage. Prostate cancer was also found by the International Journal of Cancer, to be the major cause of death among autopsies of natural death cases in geriatric males. Genetic factors accounts as a doubled risk factor among above 45 age males. Diagnosis of prostate cancer is first undergone by physical examination; it is then confirmed by MRI or a tissue biopsy.

Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=223168

Treatment is surgery in case of primary stages. In case of advanced disease, radiation, chemotherapy and therapeutic drugs are prescribed to a patient. The survival rate for prostate cancer is at 99% in the US. Testicular cancer on the other hand has a far lesser prevalence, but unlike prostate cancer it is reported in a younger male population i.e. 20-39 years, according to the US journal: Seminars in Oncology. In the UK and U.S combined, nearly 10000 individuals are diagnosed annually with testicular cancer. However a majority of these cases are benign tumors and are therefore the most successfully cured form of cancer in humans with a high survival rate.
Surgery involving the castration of testis (inguinal orchiectomy) is usually necessary to prevent malignancy, it also forms as a safe mode of diagnostic confirmation as biopsies have been found to increase the proliferation of testicular cancer. The procedure itself is generally without any complications and cures a majority of cancer patients worldwide. However testicular cancer is highly specific to Caucasian populations and is extremely rare among Asian and African decent populations. Penile cancers are even rarer form of cancer, but unlike prostate and testicular cancer, they are commonly as a result of human papiloma virus (HPV) infection. Hence penile cancer rates are high in developing countries. Chemotherapy, antiviral therapy and surgical excision are the common mode of treatment for penile cancer.

That said, the market for male cancer therapeutics is highly fragmented hence not easily quantifiable, however the surgery and overall treatment market remains in billions of USD, with new diagnostic screening procedures and drug combinations being patented every year, each having their own market segment. They are at present one of the most sought after investment segment in the healthcare drugs industry. With entry of Asian players the prices too are bound to decrease, thereby potentially increasing the overall therapeutics market. In developing markets of Asia and South America, their poor standards along with their population size make for a large market, however unavailability of affordable diagnostic procedures and therapeutic drugs is thought to be the major reason why diagnosis is few in number and why the markets haven’t been proliferated as of yet. The rest of the world region is also bound to follow a similar pattern with increased awareness and diagnostic rates, the number of diagnosed individuals undergoing therapy in this region is however very small.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

North America
Asia Pacific
Europe
Rest of the World

This report provides comprehensive analysis of

Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=223168

Reasons for Buying this Report

This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a six-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides distinctive graphics and exemplified SWOT analysis of major market segments

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

ResearchMoz
90 State Street,
Albany, NY 12207,
United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Analysis of Male Cancer in Global Industry : Demands, Insights, Research and Forecast 2017-2020 here

News-ID: 540413 • Views:

More Releases for Asia

South East Asia Business Jet Market And Top Key Players are Asia Corporate Jet, …
By 2022, the South East Asia Business Jet Markets estimated to reach US$ XX Mn, up from US$ XX Mn in 2016, growing at a CAGR of XX% during the forecast period. The Global Business Jet Market, currently at 21 million USD, contributes the highest share in the market and is poised to grow at the fastest rate in the future. The three broad categories of business jets are Small,
RAMPF Korea – Producing in Asia for Asia
Joint Venture for the Asian markets – The international RAMPF Group has realigned the cooperation with its long-standing partner Orient Dosiertechnik from Korea with the founding of RAMPF Korea Co., Ltd. The new company based in Hwaseong City is developing and producing mixing and dispensing systems specifically for the Asian markets. Within the framework of the new joint venture based in Hwaseong City, mixing and dispensing systems are being developed and
LIXIL Asia Presents Asia Pacific Property Awards
Through its power brands GROHE and American Standard, LIXIL Asia signs a three-year deal to become the Headline Sponsor of the Asia Pacific Property Awards from 2019 until 2022. 23rd January 2019: The International Property Awards, first established in 1993, are open to residential and commercial property professionals from around the globe. They celebrate the highest levels of achievement by companies operating within the architecture, interior design, real estate and property
PEOPLEWAVE WINS ASIA TECH PODCAST PITCHDECK ASIA 2019 AWARDS
15 January 2019, Singapore – Peoplewave, Asia’s leading data-driven HR technology company, won the Asia Tech Podcast (ATP) Pitchdeck Asia 2019 Awards, being awarded “Startup Most Likely to Succeed in 2019". The 2019 Pitchdeck Asia Awards is an opportunity for the Asian Startup Ecosystem to shine a spotlight on some of its best startups. The awards were decided by a public vote. More than 7,200 votes were cast by registered LinkedIn
Undersea Defence Technology Asia, UDT Asia 2011
Latest Military Diving Technologies featured in UDT Asia Equipping Asia’s navies with the latest diving technology for asymmetric warfare and operations SINGAPORE, 17 October 2011 - Naval diving and underwater special operations is a field that is seeing increased attention and investment amongst navies in Asia. Units such as the Indonesian Navy‟s KOPASKA, the Republic of Singapore Navy‟s Naval Diving Unit (NDU), the Royal Malaysian Navy‟s PASKAL are increasingly utilising specialised equipment for conducting
Asia Diligence – Specialist Investigative Due Diligence for Asia & Beyond
Asia Diligence today announced the opening of its European Customer Services office in the United Kingdom. The office is to be managed by Steve Fowler and will focus on providing services to Asia Diligence’s European customers. Asia Diligence is also planning to open a US office in the near future, which will provide customer service to its US and North American clients. Asked to comment on the move, Luke Palmer, the